Tag Archives: No Heart Risk with Smoking-Cessation Meds

Study: No Heart Risk with Smoking-Cessation Meds

In a large, head-to-head comparison trial of major smoking-cessation therapies, use of the medications was not associated with an increased risk for heart attack or stroke, researchers reported. The incidence of major cardiovascular events was low over a year of follow-up in users of varenicline (Chantix), bupropion hydrochloride (Zyban), nicotine-replacement therapy (NRT), and placebo, and […]